EODData

ASX, BXN:

20 Oct 2025
LAST:

0.0370

CHANGE:
 0.00
OPEN:
0.0370
HIGH:
0.0390
ASK:
0.0560
VOLUME:
1.25M
CHG(%):
0.00
PREV:
0.0390
LOW:
0.0370
BID:
0.0550
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
20 Oct 250.03700.03900.03700.03701.25M
17 Oct 250.03900.03900.03700.03903.88M
16 Oct 250.03800.04000.03700.03902.99M
15 Oct 250.03600.03800.03500.03801.74M
14 Oct 250.03500.03600.03400.03503.35M
13 Oct 250.03600.03700.03300.03302.75M
10 Oct 250.03800.03800.03600.03701.45M
09 Oct 250.03800.03800.03700.03701.17M
08 Oct 250.03800.03800.03600.03602.5M
07 Oct 250.03900.04000.03600.03703.28M

COMPANY PROFILE

Name:
About:Bioxyne Limited, together with its subsidiaries, manufactures and distributes therapeutic goods, and health and wellness products in Australia, the United States, the United Kingdom, Czechia, Switzerland, France, Germany, and Japan. It operates through Pharmaceutical Manufacture and Wholesale Supply of Novel Medicines, Cannabis, Psilocybin, and MDMA; Manufacture and Distribution (Wholesale, Online, and Retail) of Consumer Health and Novel Food Products; and Wholesale of Patented Probiotics segments. The company offers active pharmaceutical ingredients and starting materials; plant-based food products, such as non-controlled cannabis extracts and cannabidiol; food grade mushroom extracts/psilocybin; medicinal and prescription cannabis products, including pastilles, vape, oral mucosal oils, flower, and suppositories; SL-NAD+ wafers; MDMA; white label manufactured wellness products; health and wellness supplements; and nootropic and skincare products. It also provides Lactobacillus fermentum VRI-003 PCC, a probiotic formulation for gastrointestinal health and immunity; Progastrim for gut and immune health; and proTract for atopic dermatitis. In addition, the company is involved in the contract manufacturing of final dose form products, including capsules, tablets, inhalables, oral solutions, and herbal preparations; import, export, manufacture, and supply of controlled drugs and medicinal products; research and development of formulations, products, and processes related to health, wellness, and medicine; and provision of telemedicine services. Further, it operates CanXChange, a machine-learning powered B2B wholesale and custody technology platform. The company offers its products to cultivators, manufacturers, pharmacies, clinics, and patients under the Breathe Life Science, Dr Watson, Mirai Solution, and Apothecary CBD brands. It sells its products through wholesale, retail, and online. Bioxyne Limited is headquartered in Sydney, Australia.
Industry:Packaged Foods
Address:50 Clarence Street, Sydney, NSW, Australia, 2000
Website:https://bioxyne.com
ISIN:AU000000BXN6
FIGI:BBG000DLY6G0

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

TECHNICAL INDICATORS

MA5:0.040.5%
MA10:0.040.0%
MA20:0.043.2%
MA50:0.0420.5%
MA100:0.0412.2%
MA200:0.044.5%
STO9:85.71 
STO14:60.00
RSI14:50.00
WPR14:-25.00
MTM14:0.00
ROC14:0.03 
ATR:0.00 
Week High:0.048.1%
Week Low:0.0312.1%
Month High:0.0527.0%
Month Low:0.034.5%
Year High:0.0662.2%
Year Low:0.01236.4%
Volatility:46.19 

RECENT SPLITS

Date Ratio
18 Mar 20121-20
08 Aug 20031-1